Golden staph, a bacterium responsible for approximately 1000 Australian deaths annually, may become more treatable thanks to new global research. The study identifies a combination of two existing antibiotics as a potential method to improve patient survival rates. Researchers found the antibiotic pairing could also reduce the severity of side effects commonly associated with current golden staph treatments. This discovery offers a promising avenue for combating the increasingly prevalent and dangerous infection. The findings suggest a shift in treatment protocols could significantly impact patient outcomes. Further research and clinical trials will be necessary to confirm these results and establish optimal dosage and administration. This offers renewed hope in the fight against antibiotic-resistant strains of golden staph.